ImmuCell
ICCC
28 hedge funds and large institutions have $8.05M invested in ImmuCell in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 3 closing their positions.
237% more capital inflows, than outflows
Capital inflows: $1.05M | Capital outflows: $311K
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
1.01% more ownership
Funds ownership: 10.14% → 11.15% (+1%)
0% more funds holding
Funds holding: 28 → 28 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Meristem Family Wealth
Minnetonka,
Minnesota
|
+$809K |
| 2 |
Essex Financial Services
Essex,
Connecticut
|
+$132K |
| 3 |
Koshinski Asset Management
Decatur,
Illinois
|
+$27.4K |
| 4 |
BlackRock
New York
|
+$24.6K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$23.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
-$106K |
| 2 |
Mercer Global Advisors
Denver,
Colorado
|
-$106K |
| 3 |
Overbrook Management Corp
New York
|
-$48.3K |
| 4 |
Morgan Stanley
New York
|
-$28.4K |
| 5 |
Renaissance Technologies
New York
|
-$17.4K |
ICCC Hedge Fund Activity: Q3 2021 in Review
28 of the 5,731 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q3 2021, worth a combined $8.05M — up 8% from $7.45M a quarter earlier.
Fund positioning in ICCC was balanced in Q3 2021: 3 funds opened new positions, 3 closed out, 7 added to existing stakes and 5 trimmed.
The largest buyer was Meristem Family Wealth, opening a new position worth an estimated $809K. The largest seller was Envestnet Asset Management, exiting entirely with an estimated $106K sold.
- 28 institutional investors held ImmuCell (ICCC) as of Q3 2021, unchanged from Q2 2021.
- Funds reported $8.05M of ImmuCell stock for Q3 2021, up 8% quarter-over-quarter.
- 3 funds opened new ImmuCell positions in Q3 2021 and 3 closed out, a net change of 0 holders.
- The largest ImmuCell buyer in Q3 2021 was Meristem Family Wealth, an estimated $809K added.
- The largest ImmuCell seller in Q3 2021 was Envestnet Asset Management, an estimated $106K sold.
Based on aggregated 13F filings for Q3 2021.